LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics

Table 3 Clinical characteristics of the stomach adenocarcinoma patients in TCGA

Clinical Characteristic	levels	N (375)	Percentage (%)
Gender	Female	134	35.7
Gender	Male	241	64.3
Age	< = 65	164	44.2
Age	> 65	207	55.8
T stage	T1	19	5.2
	T2	80	21.8
	T3	168	45.8
	T4	100	27.2
N stage	N0	111	31.1
	N1	97	27.2
	N2	75	21
	N3	74	20.7
M stage	M0	330	93
M stage	M1	25	7
Pathologic stage	Stage I	53	15.1
	Stage II	111	31.5
	Stage III	150	42.6
	Stage IV	38	10.8
Primary therapy outcome	PD	65	20.5
	SD	17	5.4
	PR	4	1.3
	CR	231	72.9
Residual tumor	R0	298	90.6
	R1	15	4.6
	R2	16	4.9
Histologic grade	G1	10	2.7
	G2	137	37.4
	G3	219	59.8
H pylori infection	No	145	89
H pylori infection	Yes	18	11
Age, median (IQR)		67 (58, 73)	67 (58, 73)

TCGA The Cancer Genome Atlas, T Tumor, N Node, M Metastasis, PD Progressive disease, SD Stable disease, PR Partial response, CR Complete response, IQR Inter quartile range

ISSN: 1471-230X